Americans Draw a Firm Line at AI-Only Diagnosis
Sixty percent of U.S. adults said they would be uncomfortable with their doctor using AI to make diagnoses or treatment decisions, a Pew Research Center survey found. The same survey placed only 30% in the comfortable camp, a gap that speaks less to abstract technophobia than to the stakes of clinical decision-making. Patients appear willing to accept automation when it supports care, but far less willing to surrender judgment at the bedside.
Just 3% said they would be open to AI making a diagnosis on its own. That number is the clearest signal in the survey: the public can imagine AI as a tool, but not as an unreviewed clinician.
Pew surveyed 3,488 U.S. adults from June 22 to 28. The findings came from an Oct. 29 report and show a public that is more permissive when AI is used for language support or image analysis, and much less tolerant when AI enters the core acts of diagnosis, coverage determination, and treatment selection. In clinical practice, those are the same points where error can be most consequential and where accountability becomes hardest to define.
Human Review Remains the Threshold for Public Acceptance
The most accepted use case in the survey was translation. Seventy-eight percent said they are open to AI translating for patients, although most still wanted a human to review the output before it affects care. That preference fits the practical reality of medical communication: translation errors can distort symptoms, medication instructions, consent discussions, and discharge plans, so human verification remains a safeguard rather than a ceremonial extra step.
A similar pattern emerged around imaging. Sixty percent were open to AI analyzing medical scans if a clinician reviews the result, while only 6% would allow AI to do it alone. The public is apparently comfortable with algorithmic pattern recognition when it acts as a second set of eyes, especially in radiology and other imaging-heavy specialties where software can sort large volumes of data quickly. Yet the data also show a hard ceiling on trust. Once AI becomes the sole reviewer, acceptance collapses.
Support fell further when the question moved from support tasks to decisions with direct clinical and financial consequences. Forty-six percent said AI should be kept out of insurance claim decisions entirely. In a system where coverage denials already shape access to care, that response suggests patients do not view algorithmic gatekeeping as a neutral administrative upgrade. They see a risk of opaque rules, disputed denials, and reduced recourse when treatment is delayed or blocked.
Confidence Weakens as AI Moves Closer to the Patient Relationship
Americans were split on whether AI will help or harm health outcomes. Thirty-seven percent expected improvement, 36% expected worse outcomes, and 26% expected little difference. That near-even split matters because it reflects not only uncertainty about performance, but uncertainty about the kind of care AI will produce. Faster processing does not automatically translate into safer care if systems amplify errors, reproduce bias, or push clinicians toward overreliance on machine output.
Among adults ages 18 to 29, pessimism has grown. Forty-five percent in that age group now expect AI to worsen patient health, compared with 29% in 2022. Younger adults often arrive with more direct exposure to digital tools, so rising concern in this group suggests the debate is shifting from novelty to skepticism as AI becomes more visible in daily life.
Privacy concerns were even sharper. Fifty-one percent said AI will make the security of patients’ health information worse, while only 8% said it will make security better. Health data are unusually sensitive because they are tied not just to identity, but to diagnoses, medications, family history, behavioral health, and sometimes prognosis. If patients believe AI increases exposure, every downstream promise of efficiency will face resistance.
The patient-doctor relationship itself also looks vulnerable in the public mind. Forty-seven percent said AI will damage that relationship. In clinical settings, trust often depends on the sense that a clinician is listening, integrating context, and accepting responsibility for the final decision. When patients imagine an algorithm sitting between them and their physician, they may worry that care becomes less personal, less explainable, and less accountable.
Trust Gaps Extend to Hospitals and Physicians
Public confidence was uneven when respondents were asked who can be trusted to ensure AI serves patients’ best interests. Forty-two percent had little or no confidence in hospital leadership, compared with 16% who had a great deal or quite a bit. Hospital executives are therefore carrying a substantial trust deficit as they deploy new systems, set guardrails, and decide how aggressively to integrate AI into operations and clinical workflows.
Physicians fared better, but not by a wide margin. Twenty-six percent expressed high confidence in doctors to ensure AI serves patients’ best interests, while 25% expressed little or no confidence. The divide suggests that many Americans still want a human clinician at the center of AI oversight, but do not assume physicians are automatically prepared to manage the technology’s risks.
The pattern fits a simple clinical principle: patients will tolerate assistance, not abdication. AI can sort scans, translate text, summarize records, and maybe help clinicians work faster. Once it begins deciding diagnoses, coverage, or treatment without a human signer on the chart, public acceptance drops sharply.
Disclosure and Oversight Now Carry Clinical Weight
The Pew findings build on an Aug. 25 report from the same survey, which found that 72% of adults consider it extremely or very important for providers to disclose when AI is used in care. Disclosure now appears to be part of the social license for medical AI. Patients are not merely asking whether the tool is accurate; they want to know when it is in play at all.
For hospitals and health systems, the message is operational as much as ethical. Introducing AI without visible oversight risks eroding trust before the first performance metric is even reviewed. Even in areas where AI may improve efficiency or reduce workload, public confidence depends on human accountability remaining explicit. The survey does not settle whether AI will improve care. It does show that most Americans want the clinician, not the machine, to remain the final authority when the diagnosis is on the line.